Back |
home / stock / gmed / gmed message board
Subject | By | Source | When |
---|---|---|---|
For a number of years I've been sending | nextofkin | investorshub | 09/23/2009 2:47:20 PM |
What can GMED shareholders do to raise our | midastouch017 | investorshub | 09/22/2009 6:55:03 PM |
Prevention is the best move to counter the | sam1933 | investorshub | 08/27/2009 10:44:47 AM |
History repeating itself? ... We'll Find Out Soon. | sam1933 | investorshub | 08/27/2009 9:11:28 AM |
If were doing a good job in the | sam1933 | investorshub | 08/26/2009 1:26:21 AM |
GenoMed's earlier memorandum: the story in full>>>>>>>>>>> | sam1933 | investorshub | 08/25/2009 11:59:30 PM |
GenoMed in Discussions with Philippines Dept of Health | midastouch017 | investorshub | 08/25/2009 4:16:19 PM |
In the Media | sam1933 | investorshub | 08/20/2009 11:30:21 PM |
A 'New Age' Tuskegee Medical Crime? | sam1933 | investorshub | 07/24/2009 9:04:11 AM |
GenoMeds Observation of Major Racial Difference in Prostate | sam1933 | investorshub | 07/22/2009 12:09:56 PM |
eps. Jeanette Mott Oxford and Rev. James Morris | midastouch017 | investorshub | 07/20/2009 2:02:49 PM |
Local business results for independent retail pharmacies near | Pennypicks | investorshub | 07/10/2009 2:11:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Globus Medical Inc. Class A Company Name:
GMED Stock Symbol:
NYSE Market:
Globus Medical Inc. Class A Website:
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) applica...
2024-05-20 06:00:04 ET Matt O'Brien from Piper Sandler issued a price target of $80.00 for GMED on 2024-05-20 04:50:00. The adjusted price target was set to $80.00. At the time of the announcement, GMED was trading at $64.4. The overall price target consensus is at $78.6...
2024-05-11 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...